These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 38128546)

  • 21. Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
    Mossner JM; Patil PG; Chou KL
    J Neural Transm (Vienna); 2019 Nov; 126(11):1479-1483. PubMed ID: 31494731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term motor outcomes of deep brain stimulation of the globus pallidus interna in Parkinson's disease patients: Five-year follow-up.
    Hwang YS; Jo S; Lee SH; Kim N; Kim MS; Jeon SR; Chung SJ
    J Neurol Sci; 2023 Jan; 444():120484. PubMed ID: 36463584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson's disease.
    Oyama G; Foote KD; Jacobson CE; Velez-Lago F; Go C; Limotai N; Zeilman PR; Romrell J; Wu SS; Neal D; Okun MS
    Parkinsonism Relat Disord; 2012 Aug; 18(7):814-8. PubMed ID: 22525365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White matter connectivity of subthalamic nucleus and globus pallidus interna targets for deep brain stimulation.
    DiRisio AC; Avecillas-Chasin JM; Platt S; Jimenez-Shahed J; Figee M; Mayberg HS; Choi KS; Kopell BH
    J Neurosurg; 2023 Nov; 139(5):1366-1375. PubMed ID: 37119111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Bocci T; Prenassi M; Arlotti M; Cogiamanian FM; Borellini L; Moro E; Lozano AM; Volkmann J; Barbieri S; Priori A; Marceglia S
    NPJ Parkinsons Dis; 2021 Sep; 7(1):88. PubMed ID: 34584095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship Between Iron Distribution in Deep Gray Matter Nuclei Measured by Quantitative Susceptibility Mapping and Motor Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease.
    Zhao W; Yang C; Tong R; Chen L; Chen M; Gillen KM; Li G; Ma C; Wang Y; Wu X; Li J
    J Magn Reson Imaging; 2023 Aug; 58(2):581-590. PubMed ID: 36594513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of subthalamic nucleus deep brain stimulation and dopaminergic treatment on dual-task manual dexterity in Parkinson's disease.
    Gülşen Ç; Koçer B; Çomoğlu SS; Gündüz AG
    Neurol Sci; 2023 May; 44(5):1633-1641. PubMed ID: 36598618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson's disease: a multicenter, retrospective study of efficacy and safety.
    Mainardi M; Ciprietti D; Pilleri M; Bonato G; Weis L; Cianci V; Biundo R; Ferreri F; Piacentino M; Landi A; Guerra A; Antonini A
    Neurol Sci; 2024 Jan; 45(1):177-185. PubMed ID: 37555874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson's disease.
    Radcliffe EM; Baumgartner AJ; Kern DS; Al Borno M; Ojemann S; Kramer DR; Thompson JA
    J Neurophysiol; 2023 Jun; 129(6):1492-1504. PubMed ID: 37198135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological effects of dual target DBS in an individual with Parkinson's disease and a sensing-enabled pulse generator.
    Cummins DD; Sandoval-Pistorius SS; Cernera S; Fernandez-Gajardo R; Hammer LH; Starr PA
    Parkinsonism Relat Disord; 2024 May; 122():106089. PubMed ID: 38460490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Efficacy of Deep Brain Stimulation to the Globus Pallidus Internus Versus the Subthalamic Nucleus in Parkinson's Disease.
    Mingming S; Zhaohui Z; Lihong Q; Xin W; Bao W; Nan L; Xuelian W
    Altern Ther Health Med; 2024 Aug; ():. PubMed ID: 39212517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.